0001752724-21-194564.txt : 20210913
0001752724-21-194564.hdr.sgml : 20210913
20210913172151
ACCESSION NUMBER: 0001752724-21-194564
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 3
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210913
DATE AS OF CHANGE: 20210913
EFFECTIVENESS DATE: 20210913
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Highland Funds I
CENTRAL INDEX KEY: 0001354917
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-21866
FILM NUMBER: 211250508
BUSINESS ADDRESS:
STREET 1: 2515 MCKINNEY AVENUE
STREET 2: SUITE 1100
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: 833-697-6246
MAIL ADDRESS:
STREET 1: 2515 MCKINNEY AVENUE
STREET 2: SUITE 1100
CITY: DALLAS
STATE: TX
ZIP: 75201
FORMER COMPANY:
FORMER CONFORMED NAME: PYXIS FUNDS I
DATE OF NAME CHANGE: 20120109
FORMER COMPANY:
FORMER CONFORMED NAME: Highland Funds I
DATE OF NAME CHANGE: 20060302
0001354917
S000021242
Highland Healthcare Opportunities Fund
C000060521
Class A
HHCAX
C000060522
Class C
HHCCX
C000060523
Class Z
HHCZX
0001354917
S000038289
Highland/iBoxx Senior Loan ETF
C000118182
Highland/iBoxx Senior Loan ETF
SNLN
0001354917
S000045651
Highland Opportunistic Credit Fund
C000141934
Class A
HNRAX
C000141935
Class C
HNRCX
C000141936
Class Z
HNRZX
0001354917
S000054634
NexPoint Merger Arbitrage Fund
C000171609
Class A
HMEAX
C000171610
Class C
HMECX
C000171611
Class Z
HMEZX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0001354917
XXXXXXXX
811-21866
false
false
false
N-1A
true
Highland Funds I
811-21866
0001354917
549300D4RVXJJ0JOL180
200 CRESCENT COURT
SUITE 700
DALLAS
75201
US-TX
US
972-628-4100
Highland Capital Management Fund Advisors, L.P.
300 Crescent Court
Suite 700
Dallas
75201
1-877-665-1287
Records as Advisor and Administrator for Trust
The Bank of New York Mellon
240 Greenwich Street
New York
10286
1-212-495-1784
Records as Custodian for Trust
DST Asset Manager Solutions, Inc.
311 W. 11th Street
Kansas City
64105
816-435-1000
Records As Transfer Agent For Trust
BNY Mellon Investment Servicing (US) Inc.
240 Greenwich Street
New York
10286
1-212-495-1784
Records As Transfer Agent For Trust
SEI Investments Distribution Co.
1 Freedom Valley Drive
OAKS
19456
610-676-1000
Records as Distributor for Trust
SEI INVESTMENTS GLOBAL FUNDS SERVICES
1 Freedom Valley Drive
OAKS
19456
610-676-1000
Records as Sub-Administrator for Trust
N
N
N-1A
3
N
Ethan Powell
000000000
N
John Honis
000000000
Y
Dr. Bob Froehlich
000000000
N
Bryan A. Ward
000000000
N
Jason Post
N/A
200 Crescent Court
Suite 700
Dallas
75201
XXXXXX
N
N
N
N
N
N
NexPoint Securities, Inc
8-69128
000165013
00000000000000000000
Y
SEI INVESTMENTS DISTRIBUTION CO.
8-27897
000010690
N/A
N
N
Cohen & Company, Ltd.
600
N/A
N
N
N
N
N
N
N
Highland Healthcare Opportunities Fund
S000021242
549300G5T2BUVOTD6774
N
3
0
0
N/A
Y
N
Y
N
N
BNY Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Revenue sharing split
1115459.25
2982.00000000
Rule 22d-1 (17 CFR 270.22d-1)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 32a-4 (17 CFR 270.32a-4)
N
N
N
N
Highland Capital Management Fund Advisors, L.P.
801-69968
000149653
5493002K2NSYVU046L11
N
DST Systems, Inc.
084-00448
21B7QCD05XOK0YTYOP98
N
N
N
S&P
549300U4VWNITEKO2881
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
Bloomberg
254900BF4G8VMW8GG471
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
DST Asset Manager Solutions, Inc.
084-00896
SEC file number
N
N
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
Y
Highland Capital Management Fund Advisors, L.P.
5493002K2NSYVU046L11
Y
N
N
Highland Capital Funds Distributor Inc
8-69128
000165013
N/A
0.00
NexBank Securities, Inc.
8-66705
000133267
5493000R7PCXD7JZMO73
0.00
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
PIPER JAFFRAY
008-15204
000000665
549300GRQCWQ3XGH0H10
2779.72000000
MERRILL LYNCH, PIERCE, FENNER & SMITH
008-07221
000007691
8NAV47T0Y26Q87Y0QP81
18966.13000000
SOCIETE GENERALE COWEN SECURITIES CORP.
008-40756
000023857
5493008QI0EFC5WBED75
4466.39999999
OPPENHEIMER & ASSOCIATES
008-31756
000015168
254900vh02jqr2l8xd64
12684.08000000
VIRTU FINANCIAL BD LLC
8-60815
000148390
54930088MP91YZQJT494
16188.78000000
SUNTRUST
008-47518
000036888
IYDOJBGJWY9T8XKCSX06
4913.64000000
INTERNATIONAL STRATEGY & INVESTMENT GROUP
8-43515
000028195
N/A
5300.00000000
STIFEL NICOLAUS & CO., INC.
008-01447
000000793
5WUVMA08EYG4KEUPW589
3278.44000000
J.P. MORGAN SECURITIES
008-35008
000000079
ZBUT11V806EZRVTWT807
11982.96000000
LEERINK SWANN AND COMPANY
008-48535
000039011
549300AAH7U76CEUBI94
22968.20000000
116942.75000000
0.00000000
N
26016835.85000000
N
N
N
N
Highland/iBoxx Senior Loan ETF
S000038289
254900KZ9XGLUQ76VB43
N
1
0
0
Exchange-Traded Fund
N
N
-3.06
-3.71
16.03774414
14.6163696
Y
N
N
N
N/A
N/A
N/A
Rule 22d-1 (17 CFR 270.22d-1)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
Y
N
Highland Capital Management Fund Advisors, L.P.
801-69968
000149653
5493002K2NSYVU046L11
N
BNY Mellon Investment Servicing (US) Inc.
084-01761
549300CFZQLI9QMJ1Z03
N
N
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
S&P
549300U4VWNITEKO2881
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
Bloomberg
254900BF4G8VMW8GG471
N
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
SEI Investments Distribution Co.
008-27897
SEC File Number
Y
N
N
SEI INVESTMENTS GLOBAL FUNDS SERVICES
801-24593
SEC FILE NUMBER
N
N
N
NexBank Securities, Inc.
8-66705
000133267
5493000R7PCXD7JZMO73
0.00
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
Highland Capital Funds Distributor Inc
8-69128
000165013
N/A
0.00
0.00000000
BANK OF AMERICA
008-69787
000283942
549300HN4UKV1E2R3U73
73428163.64
BARCLAYS CAPITAL INC.
008-41342
000019714
AC28XWWI3WIBK2824319
55862356.41
MORGAN STANLEY SMITH BARNEY LLC
008-15869
000111386
549300RG2G4JJSK1V155
38498790.32
CITIGROUP GLOBAL MARKETS
008-08177
000007059
MBNUM2BPBDO7JBLYG310
26901102.74
JP MORGAN
008-35008
000000079
ZBUT11V806EZRVTWT807
13835218.92
DEUTSCHE BANK SECURITIES, INC.
008-17822
000002525
9J6MBOOO7BECTDTUZW19
8712665.92
BANK OF NOVA SCOTIA
008-03716
000002739
549300BLWPABP1VNME36
5573875
JEFFERIES LLC
008-15074
000002347
58PU97L1C0WSRCWADL48
4422777.95
NOMURA SECURITIES INTERNATIONAL, INC.
008-15255
000004297
OXTKY6Q8X53C9ILVV871
2390125
MERRILL LYNCH, PIERCE, FENNER & SMITH
008-07221
000007691
8NAV47T0Y26Q87Y0QP81
1243668.57
611837507.99000001
N
61373474.54999999
N
N
N
NexPoint Merger Arbitrage Fund
S000054634
549300O24D7XG2BMWB63
N
3
0
0
N/A
Y
N
Y
N
N
BNY Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Revenue sharing split
2234482.55
20322.00000000
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 32a-4 (17 CFR 270.32a-4)
Rule 22d-1 (17 CFR 270.22d-1)
Y
Y
Y
N
Highland Capital Management Fund Advisors, L.P.
801-69968
000149653
5493002K2NSYVU046L11
N
DST Asset Manager Solutions, Inc.
084-00896
N/A
N
N
N
S&P
549300U4VWNITEKO2881
N
Thomson Reuters Corporation
549300561UZND4C7B569
CA
N
Bloomberg
254900BF4G8VMW8GG471
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Intercontinental Exchange, Inc.
5493000F4ZO33MV32P92
N
Pricing Direct
549300WIC0TOJ7N7GD54
N
N
Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
DST Asset Manager Solutions, Inc.
084-00896
SEC file number
N
N
N
Highland Capital Management Fund Advisors, L.P.
5493002K2NSYVU046L11
Y
N
SEI Investments Global Funds Services
801-24593
SEC File Number
N
Y
N
SEI Investments Distribution Co.
8-27897
000010690
N/A
0.00
Highland Capital Funds Distributor Inc
8-69128
000165013
N/A
0.00
NexBank Securities, Inc.
8-66705
000133267
5493000R7PCXD7JZMO73
0.00
CANTOR FITZGERALD & CO.
008-00201
000000134
5493004J7H4GCPG6OB62
119573.08000000
GOLDMAN, SACHS & CO.
008-00129
000000361
FOR8UP27PHTHYVLBNG30
70457.81000000
MORGAN STANLEY & CO, INC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
19796.43000000
VIRTU FINANCIAL BD LLC
8-60815
000148390
54930088MP91YZQJT494
42704.31000000
SOCIETE GENERALE COWEN SECURITIES CORP.
008-40756
000023857
5493008QI0EFC5WBED75
38135.87999999
MKM PARTNERS
8-50311
000043552
54930015ODYESNP2QX15
18949.51000000
J.P. MORGAN SECURITIES
008-35008
000000079
ZBUT11V806EZRVTWT807
140492.83000000
MERRILL LYNCH, PIERCE, FENNER & SMITH
008-07221
000007691
8NAV47T0Y26Q87Y0QP81
7993.76000000
SUNTRUST
008-47518
000036888
IYDOJBGJWY9T8XKCSX06
11502.08000000
BLOOMBERG TRADEBOOK
008-49219
000040881
N/A
96788.04999999
596728.74000000
0.00
N
99754385.28000000
N
N
N
N
Highland/iBoxx Senior Loan ETF
S000038289
N
100000.00000000
100.00000000
0.00000000
0.00000000
0.00000000
100.00000000
0.00000000
0.00000000
0.00000000
0.00000000
500.00000000
0.00000000
0.00000000
500.00000000
0.00000000
0.00000000
500.00000000
0.00000000
0.00000000
500.00000000
0.00000000
N
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
NCEN_HHOF.txt
INTERNAL CONTROL LETTER
REPORT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Trustees of
Highland Funds I
In planning and performing our audit of the
financial statements of Highland Funds I comprising
Highland Healthcare Opportunities Fund and NexPoint
Merger Arbitrage Fund (the Funds) as of and for the
year ended June 30, 2021, in accordance with the
standards of the Public Company Accounting
Oversight Board (United States) (PCAOB), we
considered the Funds internal control over
financial reporting, including controls over
safeguarding securities, as a basis for designing
our auditing procedures for the purpose of
expressing our opinion on the financial statements
and to comply with the requirements of Form N?CEN,
but not for the purpose of expressing an opinion on
the effectiveness of the Funds internal control
over financial reporting. Accordingly, we express
no such opinion.
The management of the Funds is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling
this responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A funds
internal control over financial reporting is a
process designed to provide reasonable assurance
regarding the reliability of financial reporting
and the preparation of financial statements for
external purposes in accordance with generally
accepted accounting principles (GAAP). A funds
internal control over financial reporting includes
those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable
detail, accurately and fairly reflect the
transactions and dispositions of the assets of the
fund; (2) provide reasonable assurance that
transactions are recorded as necessary to permit
preparation of financial statements in accordance
with GAAP, and that receipts and expenditures of
the fund are being made only in accordance with
authorizations of management and trustees of the
fund; and (3) provide reasonable assurance
regarding prevention or timely detection of
unauthorized acquisition, use or disposition of a
funds assets that could have a material effect on
the financial statements.
Because of its inherent limitations, internal
control over financial reporting may not prevent or
detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are
subject to the risk that controls may become
inadequate because of changes in conditions, or
that the degree of compliance with the policies or
procedures may deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees, in
the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency,
or combination of deficiencies, in internal control
over financial reporting, such that there is a
reasonable possibility that a material misstatement
of the Funds annual or interim financial statements
will not be prevented or detected on a timely
basis.
Our consideration of the Funds internal control over
financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control that might be material weaknesses under
standards established by the PCAOB. However, we
noted no deficiencies in the Funds internal control
over financial reporting and its operation,
including controls over safeguarding securities,
that we consider to be a material weakness as
defined above as of June 30, 2021.
This report is intended solely for the information
and use of management and the Board of Trustees of
the Funds and the Securities and Exchange Commission
and is not intended to be and should not be used by
anyone other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
August 30, 2021
INTERNAL CONTROL RPT
3
NCEN_SNLN.txt
INTERNAL CONTROL LETTER
REPORT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Trustees of
Highland Funds I
In planning and performing our audit of the
financial statements of the Highland/iBoxx Senior
Loan ETF (the Fund) as of and for the year ended
June 30, 2021, in accordance with the standards of
the Public Company Accounting Oversight Board
(United States) (PCAOB), we considered the Funds
internal control over financial reporting,
including controls over safeguarding securities, as
a basis for designing our auditing procedures for
the purpose of expressing our opinion on the
financial statements and to comply with the
requirements of Form N?CEN, but not for the purpose
of expressing an opinion on the effectiveness of
the Funds internal control over financial
reporting. Accordingly, we express no such opinion.
The management of the Fund is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling
this responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A funds
internal control over financial reporting is a
process designed to provide reasonable assurance
regarding the reliability of financial reporting
and the preparation of financial statements for
external purposes in accordance with generally
accepted accounting principles (GAAP). A funds
internal control over financial reporting includes
those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable
detail, accurately and fairly reflect the
transactions and dispositions of the assets of the
fund; (2) provide reasonable assurance that
transactions are recorded as necessary to permit
preparation of financial statements in accordance
with GAAP, and that receipts and expenditures of
the fund are being made only in accordance with
authorizations of management and trustees of the
fund; and (3) provide reasonable assurance
regarding prevention or timely detection of
unauthorized acquisition, use or disposition of a
funds assets that could have a material effect on
the financial statements.
Because of its inherent limitations, internal
control over financial reporting may not prevent or
detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are
subject to the risk that controls may become
inadequate because of changes in conditions, or
that the degree of compliance with the policies or
procedures may deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees, in
the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency,
or combination of deficiencies, in internal control
over financial reporting, such that there is a
reasonable possibility that a material misstatement
of the Funds annual or interim financial statements
will not be prevented or detected on a timely
basis.
Our consideration of the Funds internal control over
financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control that might be material weaknesses under
standards established by the PCAOB. However, we
noted no deficiencies in the Funds internal control
over financial reporting and its operation,
including controls over safeguarding securities,
that we consider to be a material weakness as
defined above as of June 30, 2021.
This report is intended solely for the information
and use of management and the Board of Trustees of
the Fund and the Securities and Exchange Commission
and is not intended to be and should not be used by
anyone other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
August 30, 2021